Recent articles

This article was written by Amanda Gilchrist, a Participant Advisory Council Member (PAC), a Clinical Trial Education Volunteer, and Breakthrough T1D supporter. Amanda’s story details her family’s type 1 diabetes (T1D) journey, why clinical trial participation is important to her, and her experience in the PAC. The views expressed by the author are her own […]

Photos of Karen Shishino Jordan and Carlton McMillan

Karen Shishino Jordan, a long-time volunteer leader in the greater California Bay area, will serve as Breakthrough T1D (formerly JDRF) International Board of Directors (IBOD) Chair, succeeding current Chair Lisa Fishbone Wallack. Carlton McMillan, also a dedicated volunteer leader in the greater California Bay area, will serve as Vice Chair, succeeding current Vice Chair Matt Varey.     Karen’s and Carlton’s terms as Chair and Vice Chair, respectively, begin Wednesday, July 1, 2026.    Breakthrough […]

Two adults support one another by holding hands

Autoimmune diseases occur when a person’s immune system wrongly attacks the body’s healthy cells, tissues, and organs. This response can result in a range of conditions, depending on which parts of the body are affected. Autoimmune diseases are often called “invisible” because their symptoms are not always evident to the people around you. As a […]

This article was written by Alecia Wesner (pictured above, right), a Participant Advisory Council (PAC) member, a Clinical Trial Education Volunteer, and long-time Breakthrough T1D supporter. Alecia’s story details her lived experiences with type 1 diabetes, participation in clinical trials, and her journey to joining the PAC. The views expressed by the author are her […]

Ride 2025 Wrapped

You rode. We cheered you on. Together, we fueled type 1 diabetes breakthroughs! Read our wrap-up of the Breakthrough T1D Ride 2025 season.

Press releases

Read the latest press releases and statements from Breakthrough T1D.

Get the Latest T1D Updates

Sign up for our monthly mission progress newsletter, The Pipeline, to stay up to date on everything you need to know about T1D, from research to advocacy, to clinical care – and everything in between.

  • This field is for validation purposes and should be left unchanged.